header
About us
Publications 2008

  1. Anandacoomarasaamy A, Caterson I, Sambrook P, Fransen M, March L: The impact of obesity on the musculoskeletal system. Int J Obes. 32: 211-222, 2008.

  2. Anandacoomarasamy A, Bagga H, Ding C, Burkhardt D, Sambrook PN, March LM: Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. J Rheumatol. Apr 35(4): 685-90, 2008.

  3. Blyth FM, Rochat S, Cumming RG, Creasey H, Handelsman DJ, Le Couteur DG, Naganathan V, Sambrook PN, Seibel MJ, Waite LM: Pain, frailty and comorbidity in older men, The CHAMP Study. Pain. 140: 224-230, 2008.

  4. Cake M, Read R, Edwards S, Smith MM, Burkhardt D, Schiavanato A, Little C, Ghosh P: Changes in gait after bilateral meniscectomy in sheep: effect of two hyaluronan preparations. J Orthop Science, J Orthop Sci. 13: 514-523, 2008.

  5. Chen JS, Hogan JC, Lyubomirsky, Sambrook PN. Management of osteoporosis in primary care in Australia. Osteoporosis Int. in press, 2008.

  6. Chen JS, March LM, Cumming RG, Cameron ID, Simpson JM, Lord SR, Sambrook PN: Role of quantitative ultrasound to predict fracture among institutionalised older people with a history of fracture. Osteoporos Int. May 27. [Epub ahead of print], 2008.

  7. Chen JS, Simpson JM, March LM, Cameron ID, Cumming RG, Lord SR, Seibel MJ, Sambrook PN: Risk factors for fracture following a fall among older people in residential care facilities in Australia. J Am Geriatr Soc. Nov 56(11): 2020-6, 2008.

  8. Chen JS, Simpson JM, March LM, Cameron ID, Cumming RG, Lord SR, Seibel MJ, Sambrook PN: Fracture risk assessment in frail older people using clinical risk factors. Age Ageing. Sep 37(5): 536-41, 2008.

  9. Combe B, C. Codreanu, U. Fiocco, M. Gaubitz, P. P. Geusens, T. K. Kvien, K. Pavelka, P. N. Sambrook, J. S. Smolen, R. Khandker, A. Singh, J. Wajdula, Fatenejad S: Efficacy, safety, and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double blind study. Ann Rheum Dis. in press, 2008.

  10. Cranney A, Wells GA, Yestisir L, Adami C, Cooper C, Delmas P, Miller P, Papadoulos, Reginster JY, Sambrook P, Silverman P, Siris E, Adachi R: Ibandronate for the prevention of non-vertebral fractures: a pooled analysis of individual patient data. Osteoporosis Int. in press, 2008.

  11. Delbaere K, Close JC, Menz HB, Cumming RG, Cameron ID, Sambrook PN, March LM, Lord SR: Development and validation of fall risk screening tools for use in residential aged care facilities. Med J Aust. Aug 18 189(4): 193-6, 2008.

  12. Fitzgerald J, Rich C, Burkhardt D, Allen J, Herzka AS, Little CB: Evidence for articular cartilage regeneration in MRL/MpJ mice. Osteoarthritis Cartilage. 16: 1319-26, 2008.

  13. Fosang AJ and Little CB: Aggrecans and aggrecanases are targets in osteoarthritis. Nat Clin Pract Rheumatol. 4: 420-7, 2008.

  14. Fosang AJ, Last K, Stanton H, Golub SB, Little CB, Jackson DC, Brown L: Neoepitope Antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. In Matrix Metalloproteinase Protocols (2nd Ed), Humana Press 2008 (submitted Feb 2008)

  15. Geusens PP, Roux CH, Reid DM, Lems WF, Adami S, Adachi JD, Sambrook PN, Saag K, Lane NE, Hochberg MC: Drug insight: choosing a drug treatement strategy for women with osteoporosis – an evidence based clinical perspective. Nat Clin Pract Rheumatol. 4: 240-248, 2008.

  16. Hawker GA, Davis AM, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Katz JN, Dieppe P: Development and Preliminary Psychometric Testing of a New OA Pain Measure - An OARSI/OMERACT Initiative. Osteoarthritis Cartilage. Apr 16(4): 409-14, 2008.

  17. Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R: Understanding the Pain Experience in Hip and Knee Osteoarthritis – An OARSI/OMERACT Initiative. Osteoarthritis Cartilage. Apr 16(4): 415-22, 2008.

  18. Jackson C and Xue M: Activated protein C – an anticoagulant that does more than stop clots.  Int J Biochem Cell Biol. 40(12): 2692-7, 2008.

  19. Jackson C, Whitmont K, Tritton S, March L, Sambrook P, Xue M: New therapeutic applications for the anticoagulant, activated protein C. Expert Opin Biol Ther. Aug  8(8): 1109-22, 2008.

  20. Jackson M, Smith MM, Smith SM, Xue M, Jackson C, Little CB: The role of activated protein C (APC) in MMP activation and collagenolysis in cartilage. Arthritis Rheum. In Press Nov 2008

  21. Jackson Miriam, Smith Margaret, Xue Meilang, Jackson Chris, Little Chris: Activation of Cartilage Matrix Metalloproteinases by Activated Protein C. Arthr Rheum. in press

  22. Little CB and Smith MM: Animal models of osteoarthritis. Current Rheumatology Reviews 4: 175-182, 2008.

  23. March L: A fluoroscopic-guided intraarticular corticosteroid injection improved pain in osteoarthritis of the hip. ACP J Club. Jan-Feb 148(1): 13, 2008.

  24. March LM, Barcenilla AL, Cross MJ, Lapsley HM, Parker D, Brooks PM: Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin Rheumatol. May 24. [Epub ahead of print], 2008.

  25. Melrose J, Burkhardt D, Smith SM, Read R, Cake M, Taylor TKF, Dillon C, Little CB: Calcification in the ovine intervertebral disc: a model of hydroxyapatite deposition disease. Eur Spine J. Accepted Dec 23 2008.

  26. Melrose J, Fuller ES, Roughley PJ, Smith MM, Kerr B, Hughes CE, Caterson B, Little CB: Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues. Arthritis Res Ther. Jul 14,10: R79, 2008

  27. Melrose J, Hayes AJ, Whitelock JM, Little CB: Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues. Bioessays. 30: 457-69, 2008.

  28. Melrose J, Smith SM, Appleyard RC, Little CB: Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur Spine J. 17: 314-24, 2008.

  29. Melrose J, Smith SM, Little CB, Moore R, Vernon-Roberts B, Fraser R: Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies. Eur Spine J. 17: 1131-1148, 2008

  30. Melrose J, Smith SM, Smith MM, Little CB: The use of Histochoice a non-cross-linking fixative in the histological examination of the intervertebral disc, meniscus, articular and growth plate cartilages. Biotech Histochem. Feb, 83(1): 47-53, 2008.

  31. Sambrook PN, Ebeling P: Osteonecrosis of the jaw. Curr Rheum Rep. 10: 97-101, 2008.

  32. Sambrook PN: Glucocorticoid induced osteoporosis. Rheumatology, 4th Edn, Chapter 191, Mosby, editors Hochberg MC, Silman AJ, Smolen J, Weinblatt ME, Weisman MH, 2008.

  33. Sambrook, PN: Glucocorticoid osteoporosis. Int J Rheum Dis. 11: 381-385, 2008.

  34. Smith MM, Cake MA, Ghosh P, Schiavinato A, Read RA, Little CB: Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology (Oxford). 47: 1172-8, 2008.

  35. Smith MM, Sakarai G, Smith SM, Young AA, Melrose J, Stewart C, Appleyard RC, Peterson JL, Gillies M, Dart A, Sonnabend DH, Little CB: Modulation of aggrecan and ADAMTS expression in endon pathology induced by altered strain. Arthritis Rheum. 58: 1055-66, 2008

  36. Whitmont K, Reid I, Tritton S, March L, Xue M, Lee M, Fulcher G, Sambrook P, Slobedman E, Cooper A, Jackson C: Treatment of chronic leg ulcers with topical activated protein C. Arch Dermatol. Nov 144(11): 1479-83, 2008

  37. Wilson R, Belluoccio D, Little CB, Fosang AJ, Bateman JF: Proteomic characterization of cartilage degradation in vitro. Arthritis Rheum. 58: 3120-31, 2008.

  38. Xie L, Galettis A, Morris J, Jackson C, Twigg SM, Gallery ED: Intercellular adhesion molecule-1 (ICAM-1) is required for monocyte adhesion to the placental bed endothelium in diabetic human pregnancy. Diabetes Metab Res Rev. May-Jun, 24(4): 294-300, 2008.

  39. Xue A, Scarlett C, Jackson CJ and Smith R: Diagnostic and prognostic significance of uPAR and PAI-2 in pancreatic ductal adenocarcinoma using multigene assay. Pancreas. 36:160-167, 2008.

  40. Xue Aiqun, Xue Meilang, Jackson Christopher and Smith Ross C: Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol. in press.

  41. Xue M, Jackson CJ: Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes. J Invest Dermatol. Nov 128(11): 2676-85, 2008.

  42. Xue M, Smith M, Little C, Sambrook P, March L, Jackson CJ: Activated protein C mediates a healing phenotype in cultured tenocytes. J Cell Mol Med. May 2 [Epub ahead of print], 2008.

 

home | about us | publications | research | support ibj | events | fracture risk calculator
© IBJ 2001 | Site maintained by Louise Jackson
This page last updated September 5, 2009

Link to home page Link to About Us Link to Publications Link to Research Link to Support IBJ Link to Events Link to Fracture Risk Calculator